Authorized Representative Services
  • MDSS News & Events

    MDSS News & Views

Important Update Regarding UK Medical Device Vigilance Reporting _MORE Portal

We would like to bring your attention to a significant change in the UK Vigilance reporting process that will be mandatory after August 31, 2023 in the UK (see our Newsletter dated April 26, 2023). 

The AICXML mailbox, which has played a vital role in reporting adverse incidents related to Medical Devices to the MHRA, will no longer be operational beyond August 31, 2023. It is being replaced by the MORE (Manufacturer Online Reporting) portal. It is essential to highlight that any submissions sent to after August 31, 2023, will not reach the MHRA. This could result in a failure to report, which is a critical noncompliance.

MDSS has been entrusted with the mandate to report Vigilance events by most of our clients. For these clients we have consistently utilized the MORE platform for reporting since its inception. During the transition, the MHRA actively sought feedback from users, and we are pleased to share that our inputs were taken into consideration to enhance the platform. 

For those of you who report directly as manufacturers, reporting via the MORE portal requires mandatory registration. Detailed instructions for both registration and submission through the portal, along with relevant guidance and useful links, can be found on the official GOV.UK website. We advise strict adherence to these guidelines. Furthermore, if you choose to report directly, it is crucial to keep MDSS, if we are your UK Responsible Person, informed of the submissions, as outlined in the guidance: "The manufacturer should also ensure that these guidelines are made known to their UK Responsible Person ..., who should be kept informed of incident reports. This will enable their UK Responsible Person ... to fulfil their obligations.

We are excited that we introduced the new portal seamlessly in our QM System for our clients to transition to the MORE portal, aligning with the guidelines to ensure a smooth and uninterrupted submission process. MDSS will continue to offer the submission of vigilance reports to the MHRA through the MORE portal specifically for its clients. 

We value your feedback and would greatly appreciate your thoughts on the helpfulness of this Newsletter in the comment section below.

Categories: News

MHRA extended the transition period for MORE!

The MHRA has extended the deadline for full transitioning to the new MORE (On-line Reporting Environment) portal until 31 August 2023. Until the end of August submissions of vigilance reports via will still be possible. It seems feedback from actors has been received which led to the extension. However, it is recommended to make yourselves familiar with the new MORE portal as soon as possible to identify any issues with the database. The MHRA vigilance guidance was updated accordingly to reflect this information.

Please note: Reports from the old MORE account should still be downloaded until the end of April! From 1 May the old MORE portal will allow read-only access.

Comment on youregulate...

Categories: News
  • UK Responsible Person

    6 Wilmslow Road, Rusholme, Manchester M14 5TP, UK

    +44 7898 375115

  • U.S. Agent

    IL 60630

    +1 (312) 975-1694

  • Cosmetics Responsible Person

    Schiffgraben 41
    30175 Hannover

    +49 511 6262 8630

  • CH-REP

    Laurenzenvorstadt 61
    5000 Aarau

  • Importer

    Limmerstraße 15
    30451 Hannover

    +49 511 62 62 86 30


Schiffgraben 41
30175 Hannover


Stay informed